CTA Community Poll: How Do Your Oncology News-Reading Habits Compare to Your Peers?
Around 30% of poll takers indicated that they read oncology news 3 to 4 times a week and almost 25% of our respondents indicated that they read oncology news every day.
Nearly 40% of our respondents indicated that they read more than 6 journal articles a week.
The <i>Journal of Clinical Oncology</i> was the go-to resource for journal articles for almost 28% of respondents, followed by the <i>New England Journal of Medicine</i>, <i>Lancet Oncology</i>, <i>Blood</i>, and <i>JAMA</i>, respectively.
The majority of respondents access their oncology news and information from their office or home computer (48.57%) or their laptop (24.29%).
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Study Zeroes in on Cause of Castration-Resistant Prostate Cancer
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC